What's New

See highlights and a detailed table of contents of PF 34(5), September – October 2008

Compendial Notices:
Sign up to receive emails with important information on compendial announcements, as well as Pending and Non-US Standards

Highlights

Access all MSDS in one place!

Resources

Access and subscribe to USP monthly emails

USP–NF Online subscriber login

Pharmacopeial Forum Online subscriber login

Contact Information

To discuss issues and concerns about USP–NF monographs and general chapters, email or call +1-301-230-6347.

USP–NF—An Overview

What is the USP–NF?

The United States Pharmacopeia–National Formulary (USP–NF) is a book of public pharmacopeial standards. It contains standards for medicines, dosage forms, drug substances, excipients, medical devices, and dietary supplements.

USP–NF in English is available in print, online, and CD formats. USP–NF in Spanish is available in print format only.

Monographs and general chapters

The USP–NF is a single–volume combination of two official compendia, the United States Pharmacopeia (USP) and the National Formulary (NF). Monographs for drug substances and preparations are featured in the USP. Monographs for dietary supplements and ingredients appear in a separate section of the USP. Excipient monographs are in the NF.

A monograph includes the name of the ingredient or preparation; the definition; packaging, storage, and labeling requirements; and the specification. The specification consists of a series of tests, procedures for the tests, and acceptance criteria. These tests and procedures require the use of official USP Reference Standards. Medicinal ingredients and products will have the stipulated strength, quality, and purity if they conform to the requirements of the monograph and relevant general chapters.

Tests and procedures referred to in multiple monographs are described in detail in the USP–NF general chapters.
View a sample USP–NF monograph.

The General Notices provide definitions for terms used in the monographs, as well as information that is necessary to interpret the monograph requirements. USP is proposing to revise the General Notices for the USP and NF.

Official recognition

The U.S. Federal Food, Drug, and Cosmetics Act designates the USP-NF as the official compendia for drugs marketed in the United States. A drug product in the U.S. market must conform to the standards in USP-NF to avoid possible charges of adulteration and misbranding. The USP-NF is also widely used by manufacturers wishing to market therapeutic products worldwide. Meeting USP-NF standards is accepted globally as assurance of high quality.

Standards established through a public process

USP creates and continuously revises USP-NF standards through a unique public-private collaborative process, which involves the pharmaceutical industry as well as government and other interested parties from anywhere in the world. Learn more about the USP-NF standards-setting process.